A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1176-1179

  Al Tawfiq, Jaffar A ^a   Bauer, Margaret E ^a   Fortney, Kate R ^a   Katz, Barry P ^a   Hood, Antoinette F ^a   Ketterer, Margaret ^b   Apicella, Michael A ^b   Spinola, Stanley M ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Emerson Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM PILUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFOCAL MICROSCOPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HAEMOPHILUS DUCREYI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PAPULE; PRIORITY JOURNAL; PUSTULE;

ADULT; CHANCROID; DOUBLE-BLIND METHOD; FEMALE; FIMBRIAE, BACTERIAL; HAEMOPHILUS DUCREYI; HUMANS; MUTATION; PHENOTYPE; VIRULENCE;

EID: 0034118017     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315310     Document Type: Article

References (13)

1. 1. Spinola SM, Castellazzo A, Shero M, Apicella MA. Characterization of pili expressed by Haemophilus ducreyi. Microb Pathog 1990; 9:417-26.
2. 2. Desjardins M, Filion LG, Robertson S, Cameron DW. Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease. Infect Immun 1995; 63:2012-20.
3. 3. Frisk A, Roggen EL, Lagergard T. Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi. J Med Microbiol 1995; 43:192-200.
4. 4. Brentjens RJ, Ketterer M, Apicella MA, Spinola SM. Fine tangled pili expressed by Haemophilus ducreyi are a novel class of pili. J Bacteriol 1996; 178:808-16.
5. 5. Bauer ME, Spinola SM. Binding of Haemophilus ducreyi to extracellular matrix proteins. Infect Immun 1999; 67:2649-53.
6. 6. Spinola SM, Orazi A, Arno JN, et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996; 173:394-402.
7. 7. Al-Tawfiq JA, Thornton AC, Katz BP, et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178:1684-7.
8. 8. Campagnari AA, Wild LM, Griffiths GE, Karatus RJ, Wirth MA, Spinola SM. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Infect Immun 1991; 59:2601-8.
9. 9. Palmer KL, Thornton AC, Fortney KA, Hood AF, Munson RS Jr, Spinola SM. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J Infect Dis 1998; 178:191-9.
10. 10. Al-Tawfiq JA, Fortney KR, Katz BP, Elkins C, Spinola SM. An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection. J Infect Dis 2000; 181:1049-54.
11. 11. Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA. Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994; 169:1146-50.
12. 12. Hiltke TJ, Bauer ME, Klesney-Tait J, Hansen EJ, Munson RS Jr, Spinola SM. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb Pathog 1999; 26: 93-102.
13. 13. Cameron DW, Spinola SM. Comparative virulence of a Haemophilus ducreyi pilin mutant in the temperature-dependent rabbit model of chancroid. [abstract P386]. In: Program and abstracts of the International Congress of Sexually Transmitted Diseases sponsored by the International Society of Sexually Transmitted Diseases Research and the International Union against Sexually Transmitted Infections (Seville, Spain), 1997.